Genoxy

Company Overview

Snapshot

Founded in January 2021 by Ronen Sobel, Genoxy operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing a patented, natural, and nontoxic method for surface disinfection.

Business overview

Genoxy is a Health Tech & Life Sciences company developing a patented, natural, and nontoxic method for eliminating antibiotic-resistant bacteria from surfaces. Its core technology involves the bio-conversion of water into hydrogen peroxide, delivered via a desktop converter with jet technology that breaks liquid into micro-droplets for complete surface coverage without wiping. Genoxy aims to serve the healthcare industry, particularly hospitals and medical device sectors, by enhancing public safety and improving supply chain efficiency through reduced material and labor costs.

Company Intelligence Q&A

What is Genoxy's primary focus?

Genoxy's primary focus is developing a patented, natural, and nontoxic method to disinfect drug-resistant bacteria from surfaces, utilizing the bio-conversion of water into hydrogen peroxide.

When was Genoxy founded?

Genoxy was founded in January 2021.

Who is the founder of Genoxy?

Ronen Sobel is the co-founder and CEO of Genoxy.

What technology does Genoxy use for disinfection?

Genoxy employs a desktop converter with jet technology that breaks liquid into micro-droplets, ensuring complete surface coverage with its bio-converted hydrogen peroxide solution.

What are Genoxy's main objectives?

Genoxy aims to save lives and enhance supply chain efficiency by reducing material and labor costs through its disinfection technology.